EBS
Emergent BioSolutions Inc.
NYSE Pharmaceutical Preparations Accelerated filer

Key Financials

Gross Profit
$317.6M
↓ 17.7%
Operating Income
$100.1M
↑ 192.1%
Revenue
$742.9M
↓ 28.8%
Net Income
$52.6M
↑ 127.6%
EPS (Diluted)
$0.93
↑ 125.8%
Total Liabilities
$796.0M
↓ 12.2%
Total Assets
$1.3B
↓ 5.1%
Shareholders' Equity
$522.6M
↑ 8.2%

Recent SEC Filings

Form Type Filed Date Link
144 10/1/2026 View on SEC
8-K 9/14/2026 View on SEC
8-K 9/1/2026 View on SEC
SCHEDULE 13G 8/14/2026 View on SEC
3 8/12/2026 View on SEC
10-Q 8/6/2026 View on SEC
8-K 8/5/2026 View on SEC
SCHEDULE 13G/A 7/31/2026 View on SEC
SCHEDULE 13G/A 7/28/2026 View on SEC
4 7/2/2026 View on SEC

Company Information

Field Value
Ticker EBS
Company Name Emergent BioSolutions Inc.
CIK 1367644
Sector Pharmaceutical Preparations
Industry Accelerated filer
Exchange NYSE
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 240-631-3200